NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma
- Tina J. Hieken
- , David Zahrieh
- , Thomas J. Flotte
- , Roxana S. Dronca
- , Evidio Domingo-Musibay
- , Garth D. Nelson
- , Carrie A. Strand
- , Lisa A. Kottschade
- , Heather N. Montane
- , Mara A. Piltin
- , Ruqin Chen
- , Robert R. McWilliams
- , James W. Jakub
- , Samir S. Khariwala
- , Arkadiusz Z. Dudek
- , Jeffrey E. Johnson
- , Svetomir N. Markovic
- , Anastasios Dimou
- , Kendall K. Tasche
- , Matthew S. Block
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Scopus
citations